Clinical trials
Recruiting Myasthenia Gravis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 13 |
| 2025 | 6 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| argenx | 7 |
| Alexion Pharmaceuticals, Inc. | 4 |
| Janssen Research & Development, LLC | 3 |
| UCB Biopharma SRL | 3 |
| George Washington University | 2 |
| TG Therapeutics, Inc. | 2 |
| University of Missouri-Columbia | 2 |
| Ad scientiam | 1 |
| Amgen | 1 |
| Arcellx, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 47 |
| Autoimmune Diseases | 5 |
| Multiple Sclerosis | 4 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 4 |
| Autoimmune Diseases of the Nervous System | 3 |
| Amyotrophic Lateral Sclerosis | 2 |
| Atypical Hemolytic Uremic Syndrome | 2 |
| Ehlers-Danlos Syndrome | 2 |
| Fatigue | 2 |
| Glycogen Storage Disease Type II | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.